GL Pharm Tech Corp. (KOSDAQ: 204840)
South Korea
· Delayed Price · Currency is KRW 970.00
-16.00 (-1.62%)
Dec 19, 2024, 9:00 AM KST
GL Pharm Tech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Operating Revenue | 24,900 | 26,033 | 16,729 | 12,426 | 11,988 | 10,608 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | - | - | Upgrade
|
| Revenue | 24,900 | 26,033 | 16,729 | 12,426 | 11,988 | 10,608 | Upgrade
|
| Revenue Growth (YoY) | -0.72% | 55.62% | 34.63% | 3.65% | 13.01% | 32.63% | Upgrade
|
| Cost of Revenue | 15,774 | 17,350 | 11,881 | 8,677 | 8,693 | 8,678 | Upgrade
|
| Gross Profit | 9,126 | 8,683 | 4,848 | 3,749 | 3,296 | 1,930 | Upgrade
|
| Selling, General & Admin | 9,199 | 8,977 | 5,700 | 3,151 | 3,133 | 2,399 | Upgrade
|
| Research & Development | 2,048 | 2,377 | 1,968 | 2,974 | 2,518 | 2,221 | Upgrade
|
| Other Operating Expenses | 66.32 | 58.33 | 50.46 | 35.99 | 36.84 | 79.5 | Upgrade
|
| Operating Expenses | 11,657 | 11,911 | 8,103 | 6,456 | 5,941 | 5,057 | Upgrade
|
| Operating Income | -2,531 | -3,228 | -3,255 | -2,707 | -2,645 | -3,127 | Upgrade
|
| Interest Expense | -837.92 | -782.89 | -425.42 | -866.88 | -827.49 | -421.67 | Upgrade
|
| Interest & Investment Income | 241.4 | 111.27 | 74.9 | 17.12 | 44.19 | 66.55 | Upgrade
|
| Earnings From Equity Investments | -20.91 | 498.85 | 1,011 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -29.24 | -15.32 | -16.48 | -0.05 | - | 3.91 | Upgrade
|
| Other Non Operating Income (Expenses) | -289.52 | -28.66 | 64.78 | 17.92 | -130.39 | 46.17 | Upgrade
|
| EBT Excluding Unusual Items | -3,467 | -3,445 | -2,546 | -3,539 | -3,559 | -3,432 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -499.97 | - | - | - | 11.42 | Upgrade
|
| Gain (Loss) on Sale of Assets | 18.03 | 0.44 | 1,714 | -24.82 | 94.13 | 6.84 | Upgrade
|
| Asset Writedown | - | - | - | -278.13 | -2.39 | -2,144 | Upgrade
|
| Pretax Income | -3,449 | -3,944 | -832.44 | -3,842 | -3,467 | -5,558 | Upgrade
|
| Income Tax Expense | -31.34 | -195.78 | -42.28 | -107.44 | -110.6 | -42.28 | Upgrade
|
| Earnings From Continuing Operations | -3,418 | -3,749 | -790.17 | -3,734 | -3,356 | -5,515 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 6.87 | - | - | Upgrade
|
| Net Income | -3,418 | -3,749 | -790.17 | -3,727 | -3,356 | -5,515 | Upgrade
|
| Net Income to Common | -3,418 | -3,749 | -790.17 | -3,727 | -3,356 | -5,515 | Upgrade
|
| Shares Outstanding (Basic) | 71 | 62 | 62 | 51 | 45 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 71 | 62 | 62 | 51 | 45 | 36 | Upgrade
|
| Shares Change (YoY) | 13.58% | 0.34% | 21.96% | 13.03% | 25.74% | 8.23% | Upgrade
|
| EPS (Basic) | -48.40 | -60.23 | -12.74 | -73.29 | -74.60 | -154.13 | Upgrade
|
| EPS (Diluted) | -48.41 | -60.23 | -13.00 | -73.29 | -75.00 | -154.13 | Upgrade
|
| Free Cash Flow | -4,644 | -4,339 | -7,707 | -3,600 | -3,765 | -2,061 | Upgrade
|
| Free Cash Flow Per Share | -65.77 | -69.72 | -124.26 | -70.78 | -83.67 | -57.59 | Upgrade
|
| Gross Margin | 36.65% | 33.35% | 28.98% | 30.17% | 27.49% | 18.20% | Upgrade
|
| Operating Margin | -10.16% | -12.40% | -19.46% | -21.78% | -22.06% | -29.48% | Upgrade
|
| Profit Margin | -13.73% | -14.40% | -4.72% | -30.00% | -28.00% | -51.99% | Upgrade
|
| Free Cash Flow Margin | -18.65% | -16.67% | -46.07% | -28.97% | -31.40% | -19.43% | Upgrade
|
| EBITDA | -758.5 | -1,090 | -1,110 | -666.91 | -696.39 | -1,278 | Upgrade
|
| EBITDA Margin | -3.05% | -4.19% | -6.64% | -5.37% | -5.81% | -12.05% | Upgrade
|
| D&A For EBITDA | 1,772 | 2,138 | 2,145 | 2,040 | 1,949 | 1,848 | Upgrade
|
| EBIT | -2,531 | -3,228 | -3,255 | -2,707 | -2,645 | -3,127 | Upgrade
|
| EBIT Margin | -10.16% | -12.40% | -19.46% | -21.78% | -22.06% | -29.48% | Upgrade
|
| Advertising Expenses | - | 50.73 | 21.61 | 20.58 | 28.8 | 7.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.